Xeris Biopharma Director Marla Persky Executes Strategic Share Transactions Amidst Financial Momentum
Marla Persky, a director at Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), executed a series of transactions in early June 2026, selling $91,432 worth of shares before acquiring new equity stakes through RSU grants and stock options. These moves occur as Xeris Biopharma demonstrates robust financial performance, with Q1 2026 revenue reaching $83.1 m…